2015 Q3 Form 10-Q Financial Statement

#000114420415043984 Filed on July 24, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2015 Q1
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $848.1K $20.76K
YoY Change 4505.13% -23.86%
Operating Profit -$20.76K
YoY Change -34.93%
Interest Expense $1.205K $1.017K
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.205K
YoY Change
Pretax Income -$21.77K
YoY Change -31.74%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$849.3K -$21.77K
YoY Change 4511.68% -31.74%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 44.53M shares 7.745M shares 7.745M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q2 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00 $0.00
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $3.905K $5.608K $2.675K
YoY Change -52.09% -89.97%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.905K $5.608K $2.675K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $3.905K $5.608K $2.675K
YoY Change -52.09% -89.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.00K
YoY Change 200.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $210.8K $187.5K
YoY Change 182.3%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $210.8K $187.5K
Total Long-Term Liabilities
Total Liabilities $951.6K $210.8K $187.5K
YoY Change 676.07% 182.3%
SHAREHOLDERS EQUITY
Retained Earnings -$2.055M -$982.0K -$960.3K
YoY Change 131.66% 18.56%
Common Stock $4.236K $4.453K $4.453K
YoY Change 446.58% 474.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$947.7K -$205.2K -$184.8K
YoY Change
Total Liabilities & Shareholders Equity $3.905K $5.608K $2.675K
YoY Change -52.09% -89.97%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2015 Q1
OPERATING ACTIVITIES
Net Income -$849.3K -$21.77K
YoY Change 4511.68% -31.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $100.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 dei Document Type
DocumentType
10-Q
CY2015Q2 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
-4636 USD
CY2015Q2 dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
CY2015Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2015Q2 us-gaap Cash
Cash
5608 USD
CY2015Q2 dei Trading Symbol
TradingSymbol
TQBY
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44533750 shares
CY2015Q1 us-gaap Cash
Cash
2675 USD
CY2015Q2 dei Amendment Flag
AmendmentFlag
false
CY2015Q2 us-gaap Inventory Net
InventoryNet
0 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
0 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
5608 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
2675 USD
CY2015Q2 us-gaap Assets
Assets
5608 USD
CY2015Q1 us-gaap Assets
Assets
2675 USD
CY2015Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
178327 USD
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
169966 USD
CY2015Q2 us-gaap Notes Payable Current
NotesPayableCurrent
17500 USD
CY2015Q1 us-gaap Notes Payable Current
NotesPayableCurrent
17500 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
210827 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
187466 USD
CY2015Q2 us-gaap Liabilities
Liabilities
210827 USD
CY2015Q1 us-gaap Liabilities
Liabilities
187466 USD
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
4453 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
4453 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
772355 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
771010 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-960254 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-982027 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
-184791 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-205219 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2675 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5608 USD
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
546 USD
CY2015Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5182 USD
CY2015Q2 us-gaap Professional Fees
ProfessionalFees
1485 USD
CY2014Q2 us-gaap Professional Fees
ProfessionalFees
8400 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19271 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18862 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
20756 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
27262 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21773 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31898 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-21773 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-31898 USD
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44533750 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44533750 shares
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-20756 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31898 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
1017 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
0 USD
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q2 tqby In Kind Contribution Of Services Expense
InKindContributionOfServicesExpense
1300 USD
CY2015Q2 tqby In Kind Contribution Of Services Expense
InKindContributionOfServicesExpense
1345 USD
CY2014Q2 us-gaap Inventory Write Down
InventoryWriteDown
4912 USD
CY2015Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2014Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-270 USD
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21075 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8361 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4341 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2933 USD
CY2014Q1 us-gaap Cash
Cash
21491 USD
CY2014Q2 us-gaap Cash
Cash
17150 USD
CY2014Q2 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q2 us-gaap Interest Paid
InterestPaid
0 USD
CY2014Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2015Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2015Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1345 USD
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
4912 USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
15000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2015Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
15000 USD
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2015Q2 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
2933 USD
CY2014Q2 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-4341 USD
CY2015Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i><u>(C) Use of Estimates</u></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Significant estimates include impairment of inventory, valuation of in kind contribution of services and valuation of deferred tax assets. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i><u>(I) Concentration of Credit Risk</u></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.58in; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the three months ended June 30, 2015 there were no revenues. For the three months ended June 30, 2014 the cigar sales to one customer accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of revenues.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i><u>(M) Reclassification</u></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>&#160;</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 41.8pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain amounts from prior periods have been reclassified to conform to the current period presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q2 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2011-11-08
CY2015Q2 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
State of Nevada
CY2015Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4912 USD
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4912 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44533750 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44533750 shares
CY2015Q2 tqby Estimated Cigar Price Per Cigar
EstimatedCigarPricePerCigar
5
CY2015Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
a forward stock split on a basis of 1 for 5.75 was approved by the Company and declared effective on July 10, 2015 for stockholders of record as of June 30, 2015.

Files In Submission

Name View Source Status
0001144204-15-043984-index-headers.html Edgar Link pending
0001144204-15-043984-index.html Edgar Link pending
0001144204-15-043984.txt Edgar Link pending
0001144204-15-043984-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tqby-20150630.xml Edgar Link completed
tqby-20150630.xsd Edgar Link pending
tqby-20150630_cal.xml Edgar Link unprocessable
tqby-20150630_def.xml Edgar Link unprocessable
tqby-20150630_lab.xml Edgar Link unprocessable
tqby-20150630_pre.xml Edgar Link unprocessable
v416026_10q.htm Edgar Link pending
v416026_ex31-1.htm Edgar Link pending
v416026_ex32-1.htm Edgar Link pending